Paulette Legendre

1.4k citations

30 papers · 873 indexed · h-index 19

Co-authors: Cécile V. Denis Peter J. Lenting Olivier D. Christophe Dominique Baruch Caterina Casari Julie Rayes Ana‐Maria Navarrete Delphine Borgel
Topics: Platelet Disorders and Treatments (28 papers)Blood groups and transfusion (15 papers)Complement system in diseases (13 papers)
Cited by: Hematology Immunology Genetics
Journals: Blood PLoS ONE Biochemistry
Partner nations: France Netherlands Japan

In The Last Decade

Paulette Legendre

30 papers receiving 867 citations

Peers

Countries citing papers authored by Paulette Legendre

Since Specialization

Citations

This map shows the geographic impact of Paulette Legendre's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paulette Legendre with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paulette Legendre more than expected).

Fields of papers citing papers by Paulette Legendre

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paulette Legendre. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paulette Legendre. The network helps show where Paulette Legendre may publish in the future.

Co-authorship network of co-authors of Paulette Legendre

This figure shows the co-authorship network connecting the top 25 collaborators of Paulette Legendre. A scholar is included among the top collaborators of Paulette Legendre based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paulette Legendre. Paulette Legendre is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The VWF/LRP4/αVβ3-axis represents a novel pathway regulating proliferation of human vascular smooth muscle cells 2021 ·Cardiovascular Research ·Jérémy Lagrange,(unknown),Jean‐Baptiste Michel,(unknown),(unknown),Vincent Muczynski,Paulette Legendre,François Plénat,Guillaume Gauchotte,(unknown),Olivier D. Christophe,Peter J. Lenting,Patrick Lacolley,Cécile V. Denis,Véronique Regnault	23
2	Impaired adhesion of neutrophils expressing Slc44a2/HNA-3b to VWF protects against NETosis under venous shear rates 2021 ·Blood ·(unknown),Philippe Robert,(unknown),Victoria Tishkova,Chrissta X. Maracle,Paulette Legendre,Bart J.M. van Vlijmen,Marie‐Christine Alessi,Peter J. Lenting,Pierre‐Emmanuel Morange,Grace M. Thomas	25
3	In vivo modulation of a dominant‐negative variant in mouse models of von Willebrand disease type 2A 2020 ·Journal of Thrombosis and Haemostasis ·(unknown),Paulette Legendre,(unknown),Barbara Lunghi,Mirko Pinotti,Olivier D. Christophe,Peter J. Lenting,Cécile V. Denis,Francesco Bernardi,Caterina Casari	14
4	Macrophage scavenger receptor SR-AI contributes to the clearance of von Willebrand factor 2018 ·Haematologica ·Nikolett Wohner,Vincent Muczynski,(unknown),Paulette Legendre,Valérie Proulle,(unknown),Olivier D. Christophe,Peter J. Lenting,Cécile V. Denis,Caterina Casari	38
5	A factor VIII–nanobody fusion protein forming an ultrastable complex with VWF: effect on clearance and antibody formation 2018 ·Blood ·Vincent Muczynski,Caterina Casari,F. Moreau,(unknown),Charlotte Kawecki,Paulette Legendre,Valérie Proulle,Olivier D. Christophe,Cécile V. Denis,Peter J. Lenting	18
6	A Novel Single-Domain Antibody Against von Willebrand Factor A1 Domain Resolves Leukocyte Recruitment and Vascular Leakage During Inflammation—Brief Report 2017 ·Arteriosclerosis Thrombosis and Vascular Biology ·(unknown),Frédéric Adam,Paulette Legendre,(unknown),Valérie Proulle,Cécile V. Denis,Olivier D. Christophe,Peter J. Lenting	35
7	A genetically-engineered von Willebrand disease type 2B mouse model displays defects in hemostasis and inflammation 2016 ·Scientific Reports ·Frédéric Adam,Caterina Casari,Nicolas Prévost,Alexandre Kauskot,(unknown),Paulette Legendre,Christelle Repérant,Dominique Baruch,Jean‐Philippe Rosa,Marijke Bryckaert,Philip G. de Groot,Olivier D. Christophe,Peter J. Lenting,Cécile V. Denis	22
8	Shear stress‐independent binding of von Willebrand factor‐type 2B mutants p.R1306Q & p.V1316M to LRP1 explains their increased clearance 2015 ·Journal of Thrombosis and Haemostasis ·Nikolett Wohner,Paulette Legendre,Caterina Casari,Olivier D. Christophe,Peter J. Lenting,Cécile V. Denis	26
9	Apoptotic Platelet Events Are Not Observed in Severe von Willebrand Disease-Type 2B Mutation p.V1316M 2015 ·PLoS ONE ·Eliane Berrou,Alexandre Kauskot,Frédéric Adam,(unknown),Paulette Legendre,(unknown),Chantal Rothschild,Nicolas Prévost,Olivier D. Christophe,Peter J. Lenting,Cécile V. Denis,Jean‐Philippe Rosa,Marijke Bryckaert	3
10	Antibody-based prevention of von Willebrand factor degradation mediated by circulatory assist devices 2014 ·Thrombosis and Haemostasis ·Antoine Rauch,Paulette Legendre,Olivier D. Christophe,Jenny Goudemand,Éric Van Belle,André Vincentelli,Cécile V. Denis,Sophie Susen,Peter J. Lenting	31
11	The prognostic value of ADAMTS13 (a disintegrin and metalloprotease with thrombospondin type 1 repeats, member 13) deficiency in septic shock patients involves interleukin-6 and is not dependent on disseminated intravascular coagulation 2013 ·Critical Care ·Vincent Peigne,Élie Azoulay,Isaline Coquet,Éric Mariotte,Michaël Darmon,Paulette Legendre,(unknown),Anne Marfaing‐Koka,Martine Wolf,Benoı̂t Schlemmer,Agnès Veyradier	55
12	In Vivo Analysis of the Role of O-Glycosylations of Von Willebrand Factor 2012 ·PLoS ONE ·(unknown),(unknown),Paulette Legendre,Julie Rayes,Marijke Bryckaert,Caterina Casari,Peter J. Lenting,Olivier D. Christophe,Cécile V. Denis	33
13	A murine model to characterize the antithrombotic effect of molecules targeting human von Willebrand factor 2012 ·Blood ·Ana‐Maria Navarrete,Caterina Casari,Paulette Legendre,(unknown),Jiun‐Ruey Hu,Peter J. Lenting,Olivier D. Christophe,Cécile V. Denis	16
14	Mutation and ADAMTS13-dependent modulation of disease severity in a mouse model for von Willebrand disease type 2B 2010 ·Blood ·Julie Rayes,Martine J. Hollestelle,Paulette Legendre,(unknown),Philip G. de Groot,Olivier D. Christophe,Peter J. Lenting,Cécile V. Denis	57
15	Effect of von Willebrand disease type 2B and type 2M mutations on the susceptibility of von Willebrand factor to ADAMTS‐13 2007 ·Journal of Thrombosis and Haemostasis ·Julie Rayes,(unknown),Paulette Legendre,(unknown),Agnès Veyradier,Bernadette Obert,Anne‐Sophie Ribba,JP Girma	38
16	Decreased ADAMTS-13 (A disintegrin-like and metalloprotease with thrombospondin type 1 repeats) is associated with a poor prognosis in sepsis-induced organ failure* 2007 ·Critical Care Medicine ·Kenneth Martin,Delphine Borgel,Nicolas Lerolle,Hendrik B. Feys,Ludovic Trinquart,Karen Vanhoorelbeke,Hans Deckmyn,Paulette Legendre,Jean‐Luc Diehl,Dominique Baruch	111
17	CHO cells expressing the high affinity αIIbβ3T562N integrin demonstrate enhanced adhesion under shear 2005 ·Journal of Thrombosis and Haemostasis ·Paulette Legendre,(unknown),Julie Rayes,(unknown),Nicolas Kieffer,Dominique Baruch	9
18	Activation of integrin αIIbβ3 expressed in Chinese hamster ovary cells is required for interaction with solid‐phase von Willebrand factor 2002 ·British Journal of Haematology ·(unknown),Paulette Legendre,Nelly Kieffer,Dominique Baruch	8
19	Two Clusters of Charged Residues Located in the Electropositive Face of the Von Willebrand Factor A1 Domain Are Essential for Heparin Binding 2002 ·Biochemistry ·(unknown),Bruno O. Villoutreix,Anne‐Sophie Ribba,Paulette Legendre,Dominique Meyer,Dominique Baruch	21
20	von Willebrand factor binding to heparin in various types of von Willebrand disease 2000 ·The Hematology Journal ·(unknown),Paulette Legendre,Nadine Ajzenberg,Josiane Warszawski,Dominique Meyer,Dominique Baruch	1

About Paulette Legendre

Paulette Legendre is a scholar working on Hematology, Immunology and Immunology and Allergy, having authored 30 papers that have together received 873 indexed citations. Recurring topics across this work include Platelet Disorders and Treatments (28 papers), Blood groups and transfusion (15 papers) and Complement system in diseases (13 papers). The work is most often cited by research in Hematology (605 citations), Immunology (350 citations) and Genetics (138 citations). Paulette Legendre has collaborated with scholars based in France, Netherlands and Japan. Frequent co-authors include Cécile V. Denis, Peter J. Lenting, Olivier D. Christophe, Dominique Baruch, Caterina Casari, Julie Rayes, Ana‐Maria Navarrete, Delphine Borgel, Anne‐Sophie Ribba and Agnès Veyradier. Their work appears in journals such as Blood, PLoS ONE and Biochemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact